hoparx.orgHematology/Oncology Pharmacy Association | HOPA

Patient Education HOPA Learn Membership Resources Support MENUHistory Leadership HOPA Volunteer Groups Advocacy & Awareness Advocacy Activities Get Involved Public Policy Agenda Patient Advisory Panel Position Statements Issue Briefs Access to Pharmacists’ Care Diversity, Equity, and Inclusion at HOPA DEI Toolkit Well-Being at HOPA Wellness Toolkit HOPA Publications HOPA News Subject Matter Expertise JHOP: Journal of Hematology Oncology Pharmacy HOPA News: Late Breaking News Strategic Plan Donate Now Contact Us HOPA Learn Core Competency Program BCOP Prep & Recert BCOP Self-Study BCOP Updates Annual Conference Bundles HOPA Conferences On-Demand Conferences & Events HOPA Presenter Portal Call for Abstracts AC24 Call for Presenters HOPA Practice Management 2024 Journal Club Journal Club Call for Presenters HOPA Membership Become a Member Mentorship Program HOPA Town Hall Volunteer Activity Center Member Spotlight Oncology Special Interest Groups (SIGs) HOPA Election Center Awards and Recognition Resources Drug Updates Professional Tools Research Grants Research Grants FAQ’s Summaries of Allied Organization Meetings HOPA Oral Chemotherapy Collaborative (OCC)™️ CORONAVIRUS (COVID-19) Guidelines, Standards, and Summaries Chemotherapy Education Pharmacist’s Application to Practice Support Partnership Opportunities Advertising & Marketing Opportunities Become an Event Sponsor Commercially Supported Symposia Industry Relations Council IRC Participants Patient Education Public Service Announcement for Adults 55+ Patient Assistance Programs Time to Talk Immuno-Oncology™ CINV: Time to Talk Latest News HOPA Apparel Shop Log In Careers HOPA Central DonateHistory Leadership HOPA Volunteer Groups Advocacy & Awareness Advocacy Activities Get Involved Public Policy Agenda Patient Advisory Panel Position Statements Issue Briefs Access to Pharmacists’ Care Diversity, Equity, and Inclusion at HOPA DEI Toolkit Well-Being at HOPA Wellness Toolkit HOPA Publications HOPA News Subject Matter Expertise JHOP: Journal of Hematology Oncology Pharmacy HOPA News: Late Breaking News Strategic Plan Donate Now Contact Us HOPA Learn Core Competency Program BCOP Prep & Recert BCOP Self-Study BCOP Updates Annual Conference Bundles HOPA Conferences On-Demand Conferences & Events HOPA Presenter Portal Call for Abstracts AC24 Call for Presenters HOPA Practice Management 2024 Journal Club Journal Club Call for Presenters HOPA Membership Become a Member Mentorship Program HOPA Town Hall Volunteer Activity Center Member Spotlight Oncology Special Interest Groups (SIGs) HOPA Election Center Awards and Recognition Resources Drug Updates Professional Tools Research Grants Research Grants FAQ’s Summaries of Allied Organization Meetings HOPA Oral Chemotherapy Collaborative (OCC)™️ CORONAVIRUS (COVID-19) Guidelines, Standards, and Summaries Chemotherapy Education Pharmacist’s Application to Practice Support Partnership Opportunities Advertising & Marketing Opportunities Become an Event Sponsor Commercially Supported Symposia Industry Relations Council IRC Participants Patient Education Public Service Announcement for Adults 55+ Patient Assistance Programs Time to Talk Immuno-Oncology™ CINV: Time to Talk Latest News HOPA Apparel Shop Log In Careers HOPA Central Donate 20 Years of Optimizing Cancer Care: 2004-2024 Learn more about HOPA Learn more about HOPA Education Fall Practice Managment is now a Webinar! Become a Practice Management speaker for Fall 2024 Learn More Education & Collaboration Earn 4.5 BCOP CEs Access an incredible educational opportunity for an affordable price, following Oncology Pharmacist Connect! Learn More Education New 2024 Courses Released for your Learning! Get up to 9 ACPE/BCOP CEs Learn More Publication Read Now: HOPA News - Vol. 21 is. 1 New Horizons for Resectable Non-Small Cell Lung Cancer: Updates in Perioperative Treatment. Learn More Membership HOPA President Committed to Direct Patient Care, Especially for Veterans with Cancer Jolynn Sessions, PharmD, BCOP, CPP, FHOPA was installed as President of HOPA. Learn More Featured Education Fall Practice Managment is now a Webinar! Education & Collaboration Earn 4.5 BCOP CEs Education New 2024 Courses Released for your Learning! Publication Read Now: HOPA News - Vol. 21 is. 1 Membership HOPA President Committed to Direct Patient Care, Especially for Veterans with Cancer Latest News See All Latest News Right Pointing Arrow HOPA News Late Breaking News Late-Breaking HOPA News: EV-302 and CheckMate 901 Trials and Other Genitourinary Studies December 13, 2023 In October of 2023, several practice-changing presentations about genitourinary cancers were made during the annual European Society for Medical Oncology (ESMO) Congress. Membership Reflections from a Life-long Oncology Pharmacist: Unconditional Care” May 17, 2023 Siu Fun Wong, PharmD, FASHP, FCSHP Clinical Professor (Volunteer) Division of Hematology/Oncology, Department of Medicine UCI Health, Orange, CA Journal Club Dabrafenib plus Trametinib in Pediatric Glioma with BRAF V600 Mutations September 21, 2023 Detection of the BRAF V600E mutation in pediatric low-grade glioma has been associated with a lower response to standard chemotherapy. Explore more from HOPA Recommended Drug Updates Late Breaking News Journal Club BCOP Drug Updates Pharmacist’s Application to Practice: Repotrectinib January 25, 2024 Christopher L. Cornett II, PharmD PGY1 Acute Care Pharmacy Resident Anne E Hitron, PharmD, MS, MBA, BCOP ,Oncology Pharmacy Specialist, Baptist Health Louisville, Louisville, Kentucky Journal Club Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer May 04, 2024 The data from this trial confirm that FTD–TPI plus bevacizumab is an effective treatment option for patients with refractory metastatic colorectal cancer, irrespective of mutational status, which side the tumor is on, and whether patients have previously Late Breaking News Adapting Investigational Drug Services During a Pandemic October 06, 2022 Recommendations for future preparedness from the Hematology/Oncology Pharmacy Association Investigational Drug Services Special Interest Group Drug Updates Pharmacist’s Application to Practice: Momelotinib January 11, 2024 Diana Mansour, PharmD, BCOP, Clinical Pharmacy Specialist, Charles M Gallagher, PharmD, PGY2 Oncology Pharmacy Resident; Kelsea Seago, PharmD, BCOP, Clinical Pharmacy Specialist, allfrom WVUH Hospitals, write about Momelotinib. Late Breaking News Late-Breaking HOPA News: RUBY5 and NRG GY018/Keynote-868 Trial June 26, 2023 The use of molecular classification within endometrial cancer has continued to evolve with the incorporation of biomarker-driven therapy . Drug Updates Pharmacist’s Application to Practice: Hepzato Kit™ January 11, 2024 Lainey Vargo, PharmD, PGY2-Oncology Resident Katie Murto, PharmD, BCOP and Crystal Heise, PharmD, BCOP WVUH Hospitals, Morgantown, West Virginia. Journal Club Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC November 23, 2023 First-line treatment with osimertinib–chemotherapy led to significantly longer progression-free survival than osimertinib monotherapy among patients with EGFR-mutated advanced NSCLC. Journal Club Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study October 23, 2023 Amivantamab–chemotherapy improved PFS and intracranial PFS versus chemotherapy.Patient Education HOPA Learn HOPA Membership Resources Support Latest News Contact Us Privacy Policy ©2024 Hematology/Oncology Pharmacy Association What are you looking for?...